Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCPR.L Regulatory News (CPR)

  • There is currently no data for CPR

Form 8 (OPD) - Carpetright plc

4 Nov 2019 14:45

Meditor Capital Management Ltd - Form 8 (OPD) - Carpetright plc

Meditor Capital Management Ltd - Form 8 (OPD) - Carpetright plc

PR Newswire

London, November 4

FORM 8 (OPD)

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Meditor Capital Management Limited (“MCML”).
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.Meditor European Master Fund Limited (“MEMFL”) is the beneficial owner of the relevant securities. Both it and MCML are subsidiaries of Meditor Group Limited. MCML is discretionary investment advisor to MEMFL.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeCarpetright plc.
(d) Is the discloser the offeror or the offeree?The offeror is MEMFL.
(e) Date position held: The latest practicable date prior to the disclosure1 November 2019.
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”No.

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

Class of relevant security:
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:91,097,24129.99
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL:91,097,24129.99

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

(b) Rights to subscribe for new securities

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Details of any interests, short positions and rights to subscribe (including directors’ and other employee options) of any person acting in concert with the party to the offer making the disclosure:

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Are any Supplemental Forms attached?

Supplemental Form 8 (Open Positions)NO
Supplemental Form 8 (SBL)NO

Date of disclosure:4 November 2019
Contact name:T. Shakerchi
Telephone number:01372467779

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
13th Dec 20125:01 pmRNSDirector/PDMR Shareholding
12th Dec 20129:54 amRNSHolding(s) in Company
11th Dec 201210:34 amRNSHolding(s) in Company
11th Dec 20127:00 amRNSInterim Results
14th Nov 20124:55 pmRNSDirector/PDMR Shareholding
6th Nov 201210:34 amRNSHolding(s) in Company
31st Oct 20121:40 pmRNSTotal Voting Rights
19th Oct 20125:57 pmRNSHolding(s) in Company
19th Oct 20124:08 pmRNSDirector/PDMR Shareholding
16th Oct 20127:00 amRNSPre-close trading update
15th Oct 20122:36 pmRNSDirector/PDMR Shareholding
3rd Oct 201211:11 amRNSHolding(s) in Company
28th Sep 20124:54 pmRNSTotal Voting Rights
26th Sep 20122:41 pmRNSDirector/PDMR Shareholding
21st Sep 201210:11 amRNSDirector/PDMR Shareholding
13th Sep 20125:10 pmRNSDirector/PDMR Shareholding
6th Sep 20121:24 pmRNSResult of AGM
4th Sep 201212:07 pmRNSHolding(s) in Company
31st Aug 20124:01 pmRNSTotal Voting Rights - Replacement
31st Aug 20122:40 pmRNSHolding(s) in Company
15th Aug 201211:06 amRNSDirector/PDMR Shareholding
3rd Aug 201211:35 amRNSHolding(s) in Company
1st Aug 201210:13 amRNSHolding(s) in Company
31st Jul 20123:02 pmRNSTotal Voting Rights
24th Jul 201211:52 amRNSAnnual Financial Report
24th Jul 20127:00 amRNS1st Quarter Results
13th Jul 20125:35 pmRNSDirector/PDMR Shareholding
2nd Jul 20122:11 pmRNSChange to composition of board committees
29th Jun 20122:26 pmRNSDirector/PDMR Shareholding
29th Jun 201212:15 pmRNSDirector/PDMR Shareholding
29th Jun 201212:03 pmRNSTotal Voting Rights
28th Jun 20123:26 pmRNSDirector/PDMR Shareholding
26th Jun 201210:00 amRNSNotification of First Quarter IMS
26th Jun 20127:00 amRNSPreliminary Results
25th Jun 20124:47 pmRNSHolding(s) in Company - Correction
25th Jun 20122:35 pmRNSHolding(s) in Company
22nd Jun 20121:44 pmRNSHolding(s) in Company
21st Jun 20129:57 amRNSHolding(s) in Company
14th Jun 20125:42 pmRNSDirector/PDMR Shareholding
13th Jun 201210:21 amRNSHolding(s) in Company
8th Jun 201210:44 amRNSHolding(s) in Company
31st May 20123:14 pmRNSTotal Voting Rights
21st May 20121:44 pmRNSHolding(s) in Company
15th May 20123:40 pmRNSDirector/PDMR Shareholding
11th May 201210:26 amRNSBoard Succession Plans
1st May 20123:03 pmRNSHolding(s) in Company
30th Apr 201212:05 pmRNSTotal Voting Rights
24th Apr 201212:28 pmRNSReplacement: Trading Statement
24th Apr 20127:00 amRNSTrading Statement
16th Apr 20124:09 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.